HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,947,092 | -12.1% | 32,899 | -16.5% | 0.01% | 0.0% |
| Q2 2023 | $3,354,003 | -1.5% | 39,394 | -4.3% | 0.01% | -14.3% |
| Q1 2023 | $3,406,651 | +35.0% | 41,168 | +28.3% | 0.01% | +40.0% |
| Q4 2022 | $2,523,483 | +11.6% | 32,085 | +4.9% | 0.01% | 0.0% |
| Q3 2022 | $2,261,000 | -59.7% | 30,579 | -64.5% | 0.01% | -54.5% |
| Q2 2022 | $5,614,000 | +13.4% | 86,165 | +10.0% | 0.01% | +22.2% |
| Q1 2022 | $4,951,000 | +14.6% | 78,346 | -3.9% | 0.01% | +28.6% |
| Q4 2021 | $4,321,000 | -80.5% | 81,492 | -74.1% | 0.01% | -81.6% |
| Q3 2021 | $22,214,000 | +34.4% | 314,726 | +26.9% | 0.04% | +35.7% |
| Q2 2021 | $16,527,000 | +330.6% | 248,042 | +616.8% | 0.03% | +300.0% |
| Q1 2021 | $3,838,000 | +1.7% | 34,602 | +8.8% | 0.01% | 0.0% |
| Q4 2020 | $3,775,000 | +25.7% | 31,805 | -7.6% | 0.01% | +16.7% |
| Q3 2020 | $3,002,000 | -40.5% | 34,429 | -38.9% | 0.01% | -45.5% |
| Q2 2020 | $5,042,000 | -48.5% | 56,358 | -42.1% | 0.01% | -56.0% |
| Q1 2020 | $9,781,000 | -56.0% | 97,287 | -49.8% | 0.02% | -39.0% |
| Q4 2019 | $22,214,000 | -21.9% | 193,875 | -14.7% | 0.04% | -25.5% |
| Q3 2019 | $28,426,000 | +3.7% | 227,332 | -0.7% | 0.06% | +7.8% |
| Q2 2019 | $27,404,000 | +16.8% | 228,880 | -15.7% | 0.05% | +18.6% |
| Q1 2019 | $23,467,000 | -6.2% | 271,606 | +6.2% | 0.04% | -23.2% |
| Q4 2018 | $25,024,000 | -35.5% | 255,865 | -24.9% | 0.06% | -24.3% |
| Q3 2018 | $38,805,000 | +116.4% | 340,740 | +70.2% | 0.07% | +100.0% |
| Q2 2018 | $17,932,000 | +83.6% | 200,235 | +50.0% | 0.04% | +117.6% |
| Q1 2018 | $9,765,000 | +127.1% | 133,487 | +81.1% | 0.02% | +142.9% |
| Q4 2017 | $4,299,000 | +128.2% | 73,718 | +75.6% | 0.01% | +133.3% |
| Q3 2017 | $1,884,000 | +103.0% | 41,981 | +78.6% | 0.00% | +50.0% |
| Q2 2017 | $928,000 | +9.2% | 23,503 | +12.2% | 0.00% | 0.0% |
| Q1 2017 | $850,000 | -9.8% | 20,950 | -11.1% | 0.00% | 0.0% |
| Q4 2016 | $942,000 | – | 23,569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |